FDA Approval Activities for this Drug…

Micardis HCT (telmisartan/hydrochlorothiazide) Tablets, 40 - 12.5 and 80 - 12.5 mg, Boehringer Ingelheim NDA 21-162 11/17/00 11/20/00 11/20/00 Micardis (telmisartan) Tablets, 20, 40 and 80 mg , Boehringer Ingelheim NDA 20-850/S5 10/23/03 Micardis (telmisartan) Tablets, 40 and 80 mg , Boehringer Ingelheim NDA 20-850 11/10/98 11/12/98 11/12/98 8/6/01 Micardis Indication: for the treatment of hypertension. Micardis (telmisartan) Tablets, Boehringer Ingelheim Micardis (telmisartan) Tablets, Boehringer Ingelheim Micardis HCT (telmisartan / hydrochlorothiazide) Tablets, Boehringer Ingelheim

For the latest approval information, please locate this drug using this index.